Kumar, Shaji K Migkou, Magdalini Bhutani, Manisha Spencer, Andrew Ailawadhi, Sikander Kalff, Anna Walcott, Farzana Pore, Nabendu Gibson, Diana Wang, Fujun others, Phase 1, first-in-human study of MEDI2228, a BCMA-targeted ADC in patients with relapsed/refractory multiple myeloma, 2020,